Related Articles
Disrupting myddosome assembly in diffuse large B‑cell lymphoma cells using the MYD88 dimerization inhibitor ST2825
Reassessment of the prognostic value of the International Prognostic Index and the revised International Prognostic Index in patients with diffuse large B-cell lymphoma: A multicentre study
Complex analysis of the TP53 tumor suppressor in mantle cell and diffuse large B-cell lymphomas
Prognostic value of MYD88 L265P mutation in diffuse large B cell lymphoma via droplet digital PCR
Prognostic impact of p53 aberrations for R-CHOP-treated patients with diffuse large B-cell lymphoma